Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probuphine Extension Study in Opioid Dependence
NCT00772785Phase 3Terminated
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- Sep 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine implant in opioid use disorder (OUD), sponsored by Titan Pharmaceuticals, Inc.. Started Sep 2008; status: terminated.
02
Drugs
buprenorphine implant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00772785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772785.